D, X., A, B., D, S., FZ, Z., & S, B. (2023). National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities. Neuropharmacology, 230, 109467. https://doi.org/10.1016/j.neuropharm.2023.109467
Chicago Style (17th ed.) CitationD, Xi, Berger A, Shurtleff D, Zia FZ, and Belouin S. "National Institutes of Health Psilocybin Research Speaker Series: State of the Science, Regulatory and Policy Landscape, Research Gaps, and Opportunities." Neuropharmacology 230 (2023): 109467. https://doi.org/10.1016/j.neuropharm.2023.109467.
MLA (9th ed.) CitationD, Xi, et al. "National Institutes of Health Psilocybin Research Speaker Series: State of the Science, Regulatory and Policy Landscape, Research Gaps, and Opportunities." Neuropharmacology, vol. 230, 2023, p. 109467, https://doi.org/10.1016/j.neuropharm.2023.109467.